AGP Executive Report
Last update: 9 hours agoMalaria Drug Resistance Watch: A new Ethiopia-focused study in Nature Microbiology analyzed 605 Plasmodium falciparum samples from 15 districts and found genetic changes suggesting partial resistance to key antimalarial medicines, including artemisinin—raising alarms for future treatment effectiveness. Hepatitis C Push: A £2.2 million Dundee-led project (DESTINE) is helping Ethiopia improve hepatitis C testing, care pathways and treatment, including running Ethiopia’s first national survey and launching targeted testing pilots for at-risk groups. Health Workforce Support: Barbados and Ethiopia signed a memorandum to enable ethical recruitment of specialist Ethiopian doctors and nurses to ease staffing shortages in Barbados’ public healthcare system. Local Care for Cleft Patients: DSP’s surplus tech partnership with Reconome is supporting Project Harar to better treat vulnerable young patients with cleft lip and palate in Ethiopia. Breastfeeding Momentum: World Breastfeeding Week 2026 coverage highlights Ethiopia and WHO calls to scale up proven breastfeeding interventions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
